Overall, we established that a short-term reduction of carbohydrate intake represents an innovative and safe way to reduce the expression of Mcl-1, a very important oncogenic protein in lymphoma cells, thereby sensitizing them to targeted chemotherapy. Here, MCL1 is linked to lymphoma.